End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | +4.69% | -.--% | -.--% |
Financials (USD)
Sales 2020 | 23.02M | Sales 2021 | 30.71M | Capitalization | 28.36M |
---|---|---|---|---|---|
Net income 2020 | 2M | Net income 2021 | 4M | EV / Sales 2020 | 2.3 x |
Net Debt 2020 | 22.85M | Net Debt 2021 | 21.03M | EV / Sales 2021 | 1.61 x |
P/E ratio 2020 |
10.5
x | P/E ratio 2021 |
5.83
x | Employees | 423 |
Yield 2020 |
2.86% | Yield 2021 |
3.03% | Free-Float | 99% |
1 day | +4.69% |
Managers | Title | Age | Since |
---|---|---|---|
Bassim Nasr
CEO | Chief Executive Officer | - | 85-12-31 |
Maen Hammoudeh
DFI | Director of Finance/CFO | - | - |
Ayman Qaddumi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hashim Al-Shawa
BRD | Director/Board Member | 48 | - |
Tawfik Habesch
BRD | Director/Board Member | 62 | - |
Bassim Nasr
CEO | Chief Executive Officer | - | 85-12-31 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 30.15M | |
+25.46% | 659B | |
+25.50% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.43% | 215B | |
+7.60% | 210B | |
-6.01% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- PHARMACARE Stock